國立虎尾科技大學 |

Gene therapy of cancer = translational approaches from preclinical studies to clinical implementation /

Record Type:	Language materials, printed : Monograph/item
Title/Author:	Gene therapy of cancer/ edited by Edmund C. Lattime, Stanton L. Gerson.
Reminder of title:	translational approaches from preclinical studies to clinical implementation /
other author:	Lattime, Edmund C.,
Published:	San Diego, CA :Academic Press, : c2002.,
Description:	1 online resource (xix, 534 p.) :ill. (some col.) :
Subject:	Cancer - Gene therapy. -
Online resource:	http://www.sciencedirect.com/science/book/9780124375512
ISBN:	9780124375512

Gene therapy of cancer = translational approaches from preclinical studies to clinical implementation /
Gene therapy of cancertranslational approaches from preclinical studies to clinical implementation /[electronic resource] :edited by Edmund C. Lattime, Stanton L. Gerson. - 2nd ed. - San Diego, CA :Academic Press,c2002. - 1 online resource (xix, 534 p.) :ill. (some col.)

Includes bibliographical references and index.

Ch. 1. Retroviral vector design for cancer gene therapy -- Ch. 2. Noninfectious gene transfer and expression systems for cancer gene therapy -- Ch. 3. Parvovirus vectors for the gene therapy of cancer -- Ch. 4. Antibody-targeted gene therapy -- Ch. 5. Ribozymes in cancer gene therapy -- Ch. 6. The advent of lentiviral vectors: prospects for cancer therapy -- Ch. 7. Immunologic targets for the gene therapy of cancer -- Ch. 8. Development of epitope-specific immunotherapies for human malignancies and premalignant lesions expressing mutated ras genes -- Ch. 9. Introduction to dendritic cells -- Ch. 10. DNA and dendritic cell-based genetic immunization against cancer -- Ch. 11. RNA-transfected dendritic cells as immunogens -- Ch. 12. In Situ immune modulation using recombinant vaccinia virus vectors: preclinical studies to clinical implementation -- Ch. 13. The use of particle-mediated gene transfer for immunotherapy of cancer -- Ch. 14. Applications of gene transfer in the adoptive immunotherapy of cancer -- Ch. 15. Update on the use of genetically modified hematopoietic stem cells for cancer therapy -- Ch. 16. Clinical applications of tumor-suppressor gene therapy -- Ch. 17. Cancer gene therapy with tumor suppressor genes involved in cell-cycle control.

The Second Edition of Gene Therapy of Cancer provides crucial updates on the basic science and ongoing research in this field, examining the state of the art technology in gene therapy and its therapeutic applications to the treatment of cancer. The clinical chapters are improved to include new areas of research and more successful trials. Chapters emphasize the scientific basis of gene therapy using immune, oncogene, antisense, pro-drug activating, and drug resistance gene targets, while other chapters discuss therapeutic approaches and clinical applications. This book is a valuable reference for anyone needing to stay abreast of the latest advances in gene therapy treatment for cancer. Key Features * Provides in-depth description of targeted systems and treatment strategies * Explains the underlying cancer biology necessary for understanding a given therapeutic approach * Extensively covers immune therapeutics of vaccines, cytokines, and peptide-induced responses * Presents translational focus with emphasis on requirements for clinical implementation * Incorporates detailed illustrations of vectors and therapeutic approaches ideal for classroom presentations and general reference.

ISBN: 9780124375512

Source: 89519:89519Elsevier Science & Technologyhttp://www.sciencedirect.comSubjects--Topical Terms:

645558
Cancer
--Gene therapy.Index Terms--Genre/Form:

554714
Electronic books.

LC Class. No.: RC271.G45 / G485 2002eb

Dewey Class. No.: 616.99/4042

National Library of Medicine Call No.: 2002 E-759

Gene therapy of cancer = translational approaches from preclinical studies to clinical implementation /
LDR:05578cam a2200433Ia 4500 001 727390
005 20120813090649.0
006 m d
007 cr cn|||||||||
008 130125s2002 caua ob 001 0 eng d
019 $a 156781097 $a 163810879 $a 166372752 $a 648303069 $a 779916499
020 $a 9780124375512
020 $a 0124375510
020 $a 9780080491363 (electronic bk.)
020 $a 0080491367 (electronic bk.)
029 1 $a NZ1 $b 12434075
029 1 $a CHVBK $b 135303486
029 1 $a AU@ $b 000048130851
035 $a ocn162129428
037 $a 89519:89519 $b Elsevier Science & Technology $n http://www.sciencedirect.com
040 $a OPELS $b eng $c OPELS $d OCLCG $d OCLCQ $d N $d YDXCP $d IDEBK $d E7B $d OCLCQ $d TULIB $d OCLCO
049 $a NTYA
050 4 $a RC271.G45 $b G485 2002eb
060 4 $a 2002 E-759
060 4 $a QZ 266 $b G326 2002
072 7 $a MED $x 062000 $2 bisacsh
072 7 $a HEA $x 039030 $2 bisacsh
082 0 4 $a 616.99/4042 $2 22
245 0 0 $a Gene therapy of cancer $h [electronic resource] : $b translational approaches from preclinical studies to clinical implementation / $c edited by Edmund C. Lattime, Stanton L. Gerson.
250 $a 2nd ed.
260 $a San Diego, CA : $b Academic Press, $c c2002.
300 $a 1 online resource (xix, 534 p.) : $b ill. (some col.)
504 $a Includes bibliographical references and index.
505 0 $a Ch. 1. Retroviral vector design for cancer gene therapy -- Ch. 2. Noninfectious gene transfer and expression systems for cancer gene therapy -- Ch. 3. Parvovirus vectors for the gene therapy of cancer -- Ch. 4. Antibody-targeted gene therapy -- Ch. 5. Ribozymes in cancer gene therapy -- Ch. 6. The advent of lentiviral vectors: prospects for cancer therapy -- Ch. 7. Immunologic targets for the gene therapy of cancer -- Ch. 8. Development of epitope-specific immunotherapies for human malignancies and premalignant lesions expressing mutated ras genes -- Ch. 9. Introduction to dendritic cells -- Ch. 10. DNA and dendritic cell-based genetic immunization against cancer -- Ch. 11. RNA-transfected dendritic cells as immunogens -- Ch. 12. In Situ immune modulation using recombinant vaccinia virus vectors: preclinical studies to clinical implementation -- Ch. 13. The use of particle-mediated gene transfer for immunotherapy of cancer -- Ch. 14. Applications of gene transfer in the adoptive immunotherapy of cancer -- Ch. 15. Update on the use of genetically modified hematopoietic stem cells for cancer therapy -- Ch. 16. Clinical applications of tumor-suppressor gene therapy -- Ch. 17. Cancer gene therapy with tumor suppressor genes involved in cell-cycle control.
505 0 $a Ch. 18. Cancer gene therapy with the p53 tumor suppressor gene -- Ch. 19. Antisense downregulation of the apoptosis-related Bcl-2 and Bcl-xl proteins: a new approach to cancer therapy -- Ch. 20. Gene therapy for chronic myelogenous leukemia -- Ch. 21. Transfer of drug-resistance genes into hematopoietic progenitors -- Ch. 22. Multidrug-resistance gene therapy in hematopoietic cell transplantation -- Ch. 23. Development and application of an engineered dihydrofolate reductase and cytidine-deaminase-based fusion genes in myeloprotection-based gene therapy strategies -- Ch. 24. Protection from antifolate toxicity by expression of drug-resistant dihydrofolate reductase -- Ch. 25. A genomic approach to the treatment of breast cancer -- Ch. 26. Antiangiogenic gene therapy -- Ch. 27. VEGF-targeted antiangiogenic gene therapy -- Ch. 28. Strategies for combining gene therapy with ionizing radiation to improve antitumor efficacy -- Ch. 29. Virotherapy with replication-selective oncolytic adenoviruses: a novel therapeutic platform for cancer -- Ch. 30. E1A cancer gene therapy -- Ch. 31. Preemptive and therapeutic uses of suicide genes for cancer and leukemia -- Ch. 32. Treatment of mesothelioma using adenoviral-mediated delivery of herpes simplex virus thymidline kinase gene in combination with ganciclovir -- Ch. 33. The use of suicide gene therapy for the treatment of malignancies of the brain -- Ch. 34. Case study of combined gene and radiation therapy as an approach in the treatment of cancer.
520 $a The Second Edition of Gene Therapy of Cancer provides crucial updates on the basic science and ongoing research in this field, examining the state of the art technology in gene therapy and its therapeutic applications to the treatment of cancer. The clinical chapters are improved to include new areas of research and more successful trials. Chapters emphasize the scientific basis of gene therapy using immune, oncogene, antisense, pro-drug activating, and drug resistance gene targets, while other chapters discuss therapeutic approaches and clinical applications. This book is a valuable reference for anyone needing to stay abreast of the latest advances in gene therapy treatment for cancer. Key Features * Provides in-depth description of targeted systems and treatment strategies * Explains the underlying cancer biology necessary for understanding a given therapeutic approach * Extensively covers immune therapeutics of vaccines, cytokines, and peptide-induced responses * Presents translational focus with emphasis on requirements for clinical implementation * Incorporates detailed illustrations of vectors and therapeutic approaches ideal for classroom presentations and general reference.
588 $a Description based on print version record.
650 0 $a Cancer $x Gene therapy. $3 645558
650 0 $a Cancer $x Immunotherapy. $3 645557
650 1 2 $a Neoplasms $x genetics. $3 778262
650 1 2 $a Neoplasms $x therapy. $3 581037
650 2 2 $a Gene Therapy $x methods. $3 780596
650 2 2 $a Immunotherapy $x methods. $3 654773
650 2 2 $a Protein Biosynthesis. $3 862044
650 6 $a Cancer $x Therapie genique. $3 873619
650 6 $a Cancer $x Immunotherapie. $3 873620
650 7 $a MEDICAL $x Oncology. $2 bisacsh $3 861622
650 7 $a HEALTH & FITNESS $x Diseases $x Cancer. $2 bisacsh $3 861623
655 4 $a Electronic books. $2 local $3 554714
700 1 $a Lattime, Edmund C., $d 1951- $3 862042
700 1 $a Gerson, Stanton L. $3 862043
856 4 0 $3 ScienceDirect $u http://www.sciencedirect.com/science/book/9780124375512
938 $a YBP Library Services $b YANK $n 2586413
938 $a ebrary $b EBRY $n ebr10186324